Comparing different wound dressings for treating third-degree burns
Official title: Randomized-controlled Trial of Wound Healing, Pain, Microbiology, Handling and Thrift of Different Wound Dressings in Patients With Split-skin Grafted Third Degree Burns
Run by University Hospital Schleswig-Holstein · NCT03674151 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing different types of wound dressings for people with third-degree burns to see which one helps them heal better and feel more comfortable.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University Hospital Schleswig-Holstein Academic / other |
| Locations | 1 site (Lübeck, Schleswig-Holstein) |
| Trial ID | NCT03674151 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with 3% to 30% total body surface area split-skin grafted third-degree burns.
✕Probably not a fit
Patients with clinical wound infections, allergies to study materials, or those on immunosuppressive therapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of various wound dressings in patients with split-skin grafted third-degree burn wounds. It compares the time to reepithelialization, pain levels, microbiological outcomes, handling, and costs associated with different dressings, including silver nylon, Manuka honey, Povidone-Iod, and hydrogel. The aim is to identify which dressing provides the best outcomes for healing and patient comfort. The study addresses the limitations of current antiseptic treatments and explores innovative options that may enhance recovery.
Why it matters
Potential benefit: If successful, this study could lead to improved healing times and reduced pain for patients with severe burn injuries.
How similar studies have gone: While some studies have explored the use of innovative wound dressings, this specific comparison of multiple new options in third-degree burn treatment is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Consent-capable male and female patients * ≥18 years of age * ≥3% and ≤30% total body surface area (TBSA) split-skin grafted third-degree burn * appropriate form of wound (not: too small) and localization (not: face, inplane surface) * ability to asses pain Exclusion Criteria: * Immunosuppressive Therapy * Clinical wound infection * Allergy against porcine material, bee poison or honey, etherial oil, propyleneglycol, silver, nylon * Relationship to someone who is involved in the study design or assessment * Participation in other clinical trials * Citizen of countries outside Europe
Where it's running
-
University of Schleswig-Holstein
Lübeck, Schleswig-Holstein, Germany Recruiting
Study contacts
- Principal investigator: Tobias Kisch, MD — University Hospital Schleswig-Holstein
- Study coordinator: Tobias Kisch, MD
- Email: tobias.kisch@uni-luebeck.de
- Phone: 00494515003580
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nicotinamide in specialized capsules for post-COVID syndrome (PCS)
People with post-COVID symptoms could try a daily 500 mg nicotinamide tablet that releases in the lower gut to see if it helps their recovery.
-
Tralokinumab for moderate-to-severe atopic dermatitis affecting the genital area
This trial will try tralokinumab in adults with moderate-to-severe atopic dermatitis involving the genital region to see if it improves genital symptoms and quality of life.
-
Prevention in PD: a six-month lifestyle program for PD and RBD
This study tests whether a six-month, structured lifestyle program combining exercise, Mediterranean diet, sleep guidance, and cognitive training helps people with Parkinson’s disease or REM sleep behavior disorder stick to healthier habits.
-
Oral ileum-targeted controlled-release nicotinic acid to reverse prediabetes
This trial tests whether taking a daily oral ileum-targeted controlled-release nicotinic acid pill for 26 weeks can help adults with prediabetes return to normal blood sugar and remains safe.
-
Early mirikizumab versus azathioprine for newly diagnosed moderate-to-severe ulcerative colitis
This trial will test whether starting mirikizumab right away instead of beginning with azathioprine helps people newly diagnosed with moderate-to-severe ulcerative colitis who did not respond well to mesalazine and steroids.
-
Kidney and heart prevention program after preeclampsia
This program will see if follow-up care plus a biobank can help identify and manage long-term kidney and heart risks for women who had preeclampsia, HELLP, eclampsia, or pregnancy-related kidney disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.